Targeting carbon nanotubes against cancer

Chiara Fabbro, Hanene Ali-Boucetta, Tatiana Da Ros, Kostas Kostarelos, Alberto Bianco, Maurizio Prato

    Research output: Contribution to journalArticlepeer-review


    The use of carbon nanotubes (CNTs) as polyvalent tools for cancer treatment is progressing at a very fast pace. The most promising approach is the targeted delivery of drugs, designed to selectively direct the therapeutic treatment towards the tumours. CNTs may offer several advantages to overcome one of the main limitations of most existing anticancer therapies, namely the lack of selectivity. Herein, an account of the existing literature on CNT-based nanomedicine for cancer treatment is given. The most significant results obtained so far in the field of drug delivery are presented for many anticancer chemotherapeutics (doxorubicin, methotrexate, taxanes, platinum analogues, camptothecine and gemcitabine), but also for immunotherapeutics and nucleic acids. Moreover, the alternative anticancer therapies based on thermal ablation and radiotherapy are discussed. The attention throughout the review is focused on the different targeting strategies proposed so far, mainly based on antibodies, but also on other specifically recognised molecules or on the application of an external magnetic field. © 2012 The Royal Society of Chemistry.
    Original languageEnglish
    Pages (from-to)3911-3926
    Number of pages15
    JournalChemical Communications
    Issue number33
    Publication statusPublished - 25 Apr 2012


    Dive into the research topics of 'Targeting carbon nanotubes against cancer'. Together they form a unique fingerprint.

    Cite this